FEATURING
- We are thrilled to welcome you back to Washington DC for the in-person/hybrid PCF Congress!
- Join us live to take advantage of numerous interpersonal networking opportunities with colleagues and educational opportunities at our robust exhibit hall with our industry partners
- An invitation-only, closed-door Chief Compliance Officer (CCO) Roundtable on the morning of Tuesday, October 25
For more information contact pcf.org.info@gmail.com.
- Annual reports and updates provided by DOJ, FDA, and OIG
- Over 30 current topics addressing crucial ethics, compliance and legal issues
- An industry-only, closed-door session for pharma and device ethics, compliance and legal professionals on Wednesday, October 26
KEYNOTE SPEAKERS
Thomas Corcoran, JD
Assistant US Attorney, District of Maryland, US Department of Justice, Baltimore, MD
Charlene Keller Fullmer, JD
Assistant United States Attorney; Deputy Chief, Affirmative Litigation; US Attorney’s Office for the Eastern District of Pennsylvania, Philadelphia, PA
Catherine (Katie) Gray, PharmD
Acting Director, Office of Prescription Drug Promotion, US Food and Drug Administration, Baltimore, MD
Mary A. Inman, JD
Whistleblower Counsel; Partner, Constantine, San Francisco, CA and London, UK
Lauren (Muldoon) Kootman, JD
Assistant Chief, Fraud Section, Criminal Division, US Department of Justice, Washington, DC
Kelly Begg Lawrence, JD
Assistant US Attorney & Chief, Health Care Fraud, District of Massachusetts, US Department of Justice, Boston, MA
Glenn Leon, JD
Fraud Section Chief, Criminal Division, US Department of Justice; Former SVP & Chief Ethics & Compliance Officer, Hewlett Packard Enterprise (HPE), Washington, DC
Mary E. Riordan, JD
Senior Counsel, Office of Counsel to the Inspector General, Office of the Inspector General, US Department of Health and Human Services, Washington, DC
Julie Ritchie Wagner, JD
Senior Assistant General Counsel, PhRMA; Former Senior Counsel, HHS Office of Counsel to the Inspector General, Washington, DC
Jamie Yavelberg, JD
Director, Fraud Section, Civil Division, US Department of Justice, Washington, DC
FEATURED FACULTY
Khelin N. Aiken, JD
Partner, North America FDA Practice, Baker McKenzie; Former Regulatory Counsel, FDA
Punkaj T. Amin, MBA, CFE
Compliance Officer, Global Wound Management, Smith & Nephew
Madelyn Archibald
Compliance Specialist, Bioventus
Meredith S. Auten, JD
Partner, Morgan, Lewis & Bockius LLP
Richard Bagger, JD
Partner and Executive Director, Christie 55 Solutions LLC
Kristiana Bankova, MS
Senior Manager, Forensics & Integrity Services, EY
Eric M. Baim, MA, JD
Partner, Dovetail Consulting Group LLC; Former VP Compliance US, Shire
Rachel Batykefer
Senior Director, Integrity & Compliance CIA Operations, Mallinckrodt
Ann E. Beasley, JD
Vice President and Chief Compliance Officer, Zai Lab
Allison Benkert, MBA
Director Global Compliance Investigations, Seagen
Joshua Blank, JD
Senior Attorney, Arnold & Porter
Eric Bolesh
Chief Operating Officer, Cutting Edge Information
Ryan Bonistalli, JD
Senior Director, Compliance, Ultragenyx Pharmaceutical
Amy B. Boring, JD
Partner, King & Spalding LLP
Keysha Bradford
Director of Compliance, Amplity Health
Adam L. Braverman, JD
Partner, Morrison & Foerster, Former US Attorney, Southern District of California
Eve M. Brunts, LLM, JD
Partner, Ropes & Gray
Terra Buckley, JD
Vice President, Head of Compliance Advisory Services, MedPro Systems
Tim Canonico
Principal, Pharmaceutical & Life Sciences, Risk & Regulatory Leader, PwC
Craig Carpenito, JD
Partner, King & Spalding; Former US Attorney, New Jersey
Cynthia Cetani, LPEC
Chief Integrity & Compliance Officer, Indivior
Cheryl Chamallas
Vice President, Head of US Compliance, argenx
Masha Chestukhin, MSJ
Associate Director, Compliance Officer R&D, IA, FMV, Sanofi Genzyme
Shoshanna Clark, JD
Head of USBU Ethics & Compliance Operations, Takeda
Steven Cohen, MBA
Associate Vice President & Chief Ethics and Compliance Officer, North America and Canada, Eli Lilly
Chris Corallo
Compliance Officer, North America, Convatec
Zachary Coseglia, JD
Managing Principal & Head of Innovation, R&G Insights Lab, Ropes & Gray
Clarissa Crain
Managing Director, Deloitte & Touche LLP
David W. Cromley, JD
Associate Vice President, Global Compliance Organization, Merck
Tiffany Cummings-Damiani, MBA
Vice President and Head of Global Compliance, Insmed Incorporated
Donna Daniels, JD
Managing Director, Forensic & Integrity Services, EY
Meenakshi Datta, JD
Partner & Global Co-leader, Healthcare Practice, Sidley Austin
Mahnu V. Davar, MA, JD
Partner, Arnold & Porter
BJ D’Avella, MBA
Life Sciences Consulting Group Leader, Paul Hastings
James M. Dawson
Vice President, Compliance Solutions, Qordata
Jake DeBoever, JD
Vice President, Chief Compliance Officer, Dermavant Sciences
Chris DePhillips, JD
Senior Vice President, Chief Operating Officer and General Counsel, Porzio Life Sciences
Stefanie A. Doebler, JD
Partner and Co-chair, Health Care Practice Group, Covington & Burling LLP
Avia M. Dunn, JD
Partner, Skadden, Arps, Slate, Meagher & Flom LLP
Gildas Durand
Principal, Forensic & Integrity Services, EY
David Falcone
Associate Vice President Global Compliance, Merz Aesthetics
J. Mark Farrar, CPA, CFE, CFF, MSJ, CIPP/US
Managing Director, Epsilon Life Sciences LLC
Nicole L. Felician, JD
Executive Director, Legal Regulatory, Digital Health, Patient Centricity, Cell Therapies, Astellas Pharma US
Margaret K. Feltz, MA, JD
Vice President, Ethics and Compliance, Chief Compliance Officer, Purdue Pharma LP
Kellie Fidler, MBA, PMP
Senior Director, Compliance Risk Assessment, Monitoring and Operations, Bristol-Myers Squibb
Melissa Fitzgerald, JD
Privacy Officer, Olympus Corporation of the Americas
Christopher Fletchall, MBA
Vice President, G & M Health LLC
Bethany Fox, JD
Vice President, Commercial Legal Affairs, Exelixis
Sara Frank, JD
Principal, Choate, Hall & Stewart LLP
Sarah A. Franklin, JD
Partner and Vice-chair, Life Sciences Litigation and Investigations Practice Group, Covington & Burling LLP
Cari A. Gallman, JD
Senior Vice President, Chief Compliance and Ethics Officer, Bristol Myers Squibb
Nereyda Garcia, JD
Head, Ethics & Compliance, US Business Unit, Takeda
Gary F. Giampetruzzi, JD
Partner, Paul Hastings
Tara K. Giunta, JD
Partner, Paul Hastings
Edward P. Glynn, MBA
Principal, Forensic & Integrity Services, EY
Gejaa T. Gobena, JD
Partner, Hogan Lovells; Former Deputy Chief, Fraud Section, Criminal Division, USDOJ
Tom Gregory, MBA, CPA
Partner, Forensic & Integrity Services, EY
Noor Haq, MBA, MS, CCEP
Executive Director, US Compliance, Amgen
Beth Hardcastle, JD
Partner, Sidley Austin LLP
Judith Haron, JD
Assistant General Counsel, PhRMA; Former Acting Chief Counsel, HHS
Todd Haugh, JD
Associate Professor of Business Law and Ethics, Kelley School of Business, Indiana University
Saul B. Helman MD, MBA
President, Epsilon Life Sciences
Kevin Henley, JD
Vice President, US Chief Compliance Officer, Otsuka America Pharmaceutical, Inc
Michael Hercz, JD
Senior Vice President & General Counsel, Sentynl
Emily F. Hodge, JD
Partner, Choate, Hall & Stewart LLP
Denis Jacob
Managing Director, Risk & Regulatory, PwC
Brenna E. Jenny, JD
Partner, Sidley
Abe Kassis, MBA, PhD
Senior Director, Global Head of Compliance and Legal Operations, Bausch + Lomb
Jeffrey Kawalek, MBA
Former Deputy, Chief Compliance Officer, Jazz Pharmaceuticals
Andrea Kocharyan, JD
Vice President, Head of Legal and Compliance, Zealand Pharma
Daniel Koerner
Senior Director, Potomac River Partners
Kirt Kraeuter, MGA
Senior Director, Corporate Compliance, Moderna
JJ Kuhn, JD
Vice President, Chief Counsel, Global Investigations, Medtronic
Stephanie Kurteff, JD, HCCP
Head of Compliance, Healthcare Compliance Officer, Medicines360
Rebekah Latchis, JD
Senior Director, Americas Office of Ethics and Compliance, Medtronic